He is the new CFO at Diamyd Medical

“Sandra has been an invaluable member of the Oxcia team, combining scientific excellence with a deep understanding of inflammation as well as our development programs,” says Ulrika Bergman Warpman, CEO. “We are delighted to see her take on this leadership role as we finalize the pre-clinical program for OXC-201 and progress our earlier projects including […]

"SciBase is now entering a new phase where the strategy and foundation is in place, and I feel this is the right time to hand over responsibility to a new CEO," says Pia Renaudin.

EQL has recruited Oskar Karmlid as its new Chief Supply Chain Officer (CSCO).

Swedish Orphan Biovitrum has announces that Guido Oelkers has informed the Board of Directors that he has decided to step down as Chief Executive Officer of Sobi to take up another position outside Sobi.

The Board of Directors has with immediate effect among its members elected Erik Gatenholm to serve as Board Chair of BICO Group AB, until a new Board Chair has been elected by the extraordinary shareholders’ meeting.

The Board of Directors and the CEO assess that having a consolidated management team on site in Uppsala, close to the core operations, will provide the best conditions for continuing to build the organization required for the next phase and for advancing development programs, the company states.

Maria Ekdahl brings more than 20 years of senior finance leadership experience, including her current role as CFO of Nasdaq Stockholm-listed pharmaceutical company, Infant Bacterial Therapeutics, and will join Biovica on October 14, 2026.